ÂÜÀòÂÒÂ×

Kevin A. Colón-Negrón, PhD, is a detail-oriented scientist in Biochemistry and Molecular Biology with over 10 years of experience in wet laboratory settings. They have held positions at companies such as OcyonBio as a Senior Manager of Technical Services, where they developed and optimized manufacturing processes in compliance with cGMP regulations. Educated at the University of California, San Francisco, Colón-Negrón's doctoral research focused on pharmacological targeting in diabetes, contributing significant insights into insulin receptor signaling pathways. Currently, they serve as a Drug Substance Manufacturing Supervisor III at AbbVie.